Published in Endocrinology on January 01, 1981
Retracted Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats. Br J Pharmacol (2002) 0.79
Diuretics in the elderly. BMJ (1988) 0.75
Effects of interrupting the renin-angiotensin system on sodium excretion in man. J Physiol (1988) 0.75
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res (1988) 3.71
Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev (1977) 3.70
The Rapunzel syndrome. An unusual complication of intestinal bezoar. Surgery (1968) 3.21
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol (1988) 2.63
Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med (1994) 2.62
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer (1989) 2.62
The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest (1996) 2.46
Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. Hypertension (1982) 2.32
Vascularized iliac crest with internal oblique muscle for immediate reconstruction after maxillectomy. Br J Oral Maxillofac Surg (2002) 2.20
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest (1997) 2.05
A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy. Oral Oncol (2006) 2.01
Molecular biology of angiotensinogen. Hypertension (1991) 1.97
Radial forearm flap donor-site complications and morbidity: a prospective study. Plast Reconstr Surg (1997) 1.96
Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int (2000) 1.93
Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer (2006) 1.84
Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol (2003) 1.81
Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ Res (1982) 1.79
Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension (1997) 1.77
Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med (1984) 1.76
Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem (1992) 1.76
Reductive assays for S-nitrosothiols: implications for measurements in biological systems. Biochem Biophys Res Commun (1998) 1.68
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A (1999) 1.60
Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol (1989) 1.55
Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. Clin Otolaryngol (2005) 1.55
Recruitment of renin gene-expressing cells in adult rat kidneys. Am J Physiol (1990) 1.50
Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension (1999) 1.50
Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J Am Soc Nephrol (1999) 1.48
Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension (1991) 1.48
Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sci U S A (1998) 1.45
Toradol, an NSAID used for renal colic, decreases renal perfusion and ureteral pressure in a canine model of unilateral ureteral obstruction. J Urol (1993) 1.45
Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol (1989) 1.45
The influence of hyperbaric oxygen on the outcome of patients treated for osteoradionecrosis: 8 year study. Int J Oral Maxillofac Surg (2007) 1.43
Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension (1995) 1.42
Survival of a free flap after arterial disconnection at six days. Br J Oral Maxillofac Surg (2004) 1.41
Adult respiratory distress syndrome after microvascular free tissue reconstruction in head and neck malignancy. Br J Oral Maxillofac Surg (1998) 1.39
The changing clinical spectrum of adrenal insufficiency. Ann Intern Med (1997) 1.38
Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ Res (1989) 1.36
Localization of angiotensinogen messenger RNA in rat aorta. Circ Res (1988) 1.35
Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest (1998) 1.34
Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol (1988) 1.33
Hypercalcemia associated with chronic lymphocytic leukemia. Arch Intern Med (1979) 1.33
Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension (1999) 1.33
Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol (1999) 1.32
Rapid adrenocorticotropic hormone test in practice. Retrospective review. Am J Med (1985) 1.31
Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med (1983) 1.30
Toxoplasmosis. Clinical experiences in a cancer hospital. Am J Med (1973) 1.29
Endothelium-dependent relaxation of rabbit aorta. II. Inhibition of relaxation stimulated by methacholine and A23187 with antagonists of arachidonic acid metabolism. J Pharmacol Exp Ther (1983) 1.28
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res (1975) 1.27
Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res (1992) 1.27
Mechanisms of endothelium-dependent vascular smooth muscle relaxation. Biochem Pharmacol (1985) 1.26
Renin and angiotensinogen gene expression in maturing rat kidney. Am J Physiol (1988) 1.26
The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone. Arch Intern Med (1972) 1.23
Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension (1992) 1.23
Correlation of histopathologic findings with clinical and radiologic assessments of cervical lymph-node metastases in oral cancer. Int J Oral Maxillofac Surg (1995) 1.22
Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med (1987) 1.20
Measurement of the negative muon anomalous magnetic moment to 0.7 ppm. Phys Rev Lett (2004) 1.19
Health-related quality of life and clinical function after primary surgery for oral cancer. Br J Oral Maxillofac Surg (2002) 1.19
Renin-angiotensin system modulates renal bradykinin production. Am J Physiol (1996) 1.18
The influence of prostate size on cancer detection. Urology (1995) 1.18
Inhibition of norepinephrine uptake in hearts by angiotensin II and analogs. J Pharmacol Exp Ther (1969) 1.18
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension (2000) 1.17
Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am J Pathol (2001) 1.17
Pericardial tamponade: a major presenting manifestation of hydralazine-induced lupus syndrome. Am J Med (1973) 1.16
Renal cell carcinoma extending into the inferior vena cava: the prognostic significance of the level of vena caval involvement. J Urol (1984) 1.16
The Charlottesville blood pressure survey: the role of the physician in hypertension case finding. Med Care (1977) 1.16
Skene's duct cyst in a newborn: case report and review of the literature. J Urol (1977) 1.13
The Charlottesville Blood-Pressure Survey. Value of repeated blood-pressure measurements. JAMA (1976) 1.13
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. Am J Cardiol (1973) 1.13
Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J Clin Invest (1988) 1.12
Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res (1977) 1.12
Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene (1989) 1.11
Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res (1981) 1.11
Stimulation of release of adrenal catecholamine by adenosine 3':5'-cyclic monophosphate and theophylline in the absence of extracellular Ca 2+ . Proc Natl Acad Sci U S A (1972) 1.11
Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid. J Pharmacol Exp Ther (1983) 1.10
Synchronous oral carcinomas: independent or common clonal origin? Cancer Res (1998) 1.10
A comparison of natriuresis after oral and intravenous sodium loading in sodium-depleted man: evidence for a gastrointestinal or portal monitor of sodium intake. Clin Sci Mol Med (1975) 1.09
The renal dopamine receptors. J Am Soc Nephrol (1992) 1.09
The effect of indomethacin on renal blood flow and uretral pressure in unilateral ureteral obstruction in a awake dogs. Invest Urol (1978) 1.09
Control of intestinal absorption by the renin-angiotensin system. Am J Physiol (1985) 1.09
Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology (1992) 1.08
Location and regulation of rat angiotensinogen messenger RNA. Hypertension (1988) 1.08
Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. Am J Physiol (1994) 1.08
The hepatic angiotensin II receptor. I. Characterization of the membrane-binding site and correlation with physiological response in hepatocytes. J Biol Chem (1982) 1.08
Normal renin secretion in hypertensive patients with primarily unilateral chronic hydronephrosis. J Urol (1974) 1.07
Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension. Hypertension (2000) 1.07
Differential muscarinic receptor mRNA expression by freshly isolated and cultured bovine aortic endothelial cells. Circ Res (1992) 1.07
Accuracy of computerized tomography in the diagnosis of colovesical fistula secondary to diverticular disease. J Urol (1995) 1.06